title: Two years serial lymphocytapheresis of progressive hyperleukocytosis in a patient with a non-Hodgkin's lymphoma.
abstract: A patient with non-Hodgkin's lymphoma was treated by ambulant lymphocytapheresis once a month over a period of 2 years and 8 months. The cytoreductive effect resulted in a decrease of white blood cells from 410/nl to 130/nl. The patient tolerated the procedure, which lasted 3-4 h, without any side effects. He could be kept in good condition by monthly apheresis. So lymphocytapheresis is a means to reduce hyperleukocytosis in patients with non-Hodgkin's lymphoma.
authors.affiliation: University Department of Transfusion Medicine, Freiburg, FRG.
authors.forename: B
authors.initials: B
authors.lastname: Heil
authors.forename: T
authors.initials: T
authors.lastname: Wüst
authors.forename: H R
authors.initials: HR
authors.lastname: Lang
authors.forename: H P
authors.initials: HP
authors.lastname: Beeser
authors.forename: H
authors.initials: H
authors.lastname: Arnold
mesh_terms: D000553:Ambulatory Care; D006801:Humans; D007937:Leukapheresis; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000628:therapy*; D007958:Leukocyte Count; D007964:Leukocytosis / Q000097:blood / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged